Kovitz Investment Group Partners LLC bought a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 11,511 shares of the real estate investment trust's stock, valued at approximately $438,000.
Several other hedge funds have also recently added to or reduced their stakes in OHI. Vanguard Group Inc. grew its position in Omega Healthcare Investors by 3.9% in the first quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust's stock worth $1,506,250,000 after buying an additional 1,492,904 shares during the last quarter. Invesco Ltd. grew its position in Omega Healthcare Investors by 122.3% in the first quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust's stock worth $92,023,000 after buying an additional 1,329,324 shares during the last quarter. Nuveen LLC acquired a new position in Omega Healthcare Investors in the first quarter worth approximately $42,513,000. Northern Trust Corp grew its position in Omega Healthcare Investors by 49.4% in the fourth quarter. Northern Trust Corp now owns 3,274,793 shares of the real estate investment trust's stock worth $123,951,000 after buying an additional 1,083,326 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in Omega Healthcare Investors by 556.1% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,028,187 shares of the real estate investment trust's stock worth $39,143,000 after buying an additional 871,472 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on OHI. Royal Bank Of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 7th. Wells Fargo & Company raised shares of Omega Healthcare Investors from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $38.00 to $41.00 in a research note on Monday, July 14th. Four investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, Omega Healthcare Investors presently has an average rating of "Hold" and a consensus price target of $42.00.
View Our Latest Stock Report on OHI
Omega Healthcare Investors Stock Down 0.4%
Shares of NYSE:OHI traded down $0.16 during trading on Friday, reaching $42.20. 1,505,971 shares of the company traded hands, compared to its average volume of 2,310,337. The firm has a fifty day simple moving average of $38.50 and a 200 day simple moving average of $37.60. The firm has a market cap of $12.45 billion, a P/E ratio of 26.05, a price-to-earnings-growth ratio of 2.24 and a beta of 0.66. Omega Healthcare Investors, Inc. has a 1-year low of $35.04 and a 1-year high of $44.42. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. The company had revenue of $235.60 million during the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company's revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter last year, the business posted $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.
Omega Healthcare Investors Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were issued a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.4%. Omega Healthcare Investors's dividend payout ratio (DPR) is currently 165.43%.
Insider Buying and Selling at Omega Healthcare Investors
In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.50% of the company's stock.
Omega Healthcare Investors Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
See Also

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.